Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MRS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TOR1AIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MOB1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABCD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AIMP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR75 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR6733 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NEK4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABCE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HBS1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRTCAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM126B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLPP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHAX - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCMTD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VAMP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DESI2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP38 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLTM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on